Since both APOE E4 carriers and individuals with AD exhibit a state of cerebral lipid dyshomeostasis, we hypothesized that APOE may play a role in regulating lipid droplets (LD) metabolism (32). The gene discussed is APOE; the disease is Alzheimer disease.